Moa of saRNAs. Small activating RNAs (saRNAs) are double-stranded RNA molecules (dsRNAs) that are precisely matched to gene promoters. The transcription of targeted genes is activated and the proteins that are missing depending on the indication are produced. © MINA Therapeutics

French Servier SA and the UK’s MiNA Therapeutics Ltd have entered into a R&D partnership to identify and develop small activating RNAs (saRNA) to treat neurological disorders.

© Luisella Planeta Leoni/Pixabay.com

Irish life sciences company Neurent Medical has closed a €21m Series B investment co-led by LSP as well as Atlantic Bridge with participation of Fountain Healthcare Partners.

© J&J

J&J subsidiary Janssen Pharma has presented updated Phase I/II antibody levels supporting a single shot administration for its COVID-19 vaccine.

The Covid-19 drug Remdesivir (purple) is incorporated into the new RNA chain during the copying process and suppresses the duplication of the coronavirus genome. © Hauke Hillen, Goran Kokic and Patrick Cramer / Max Planck Institute for Biophysical Chemistry, Göettingen, Germany

German Researchers have unraveled how remdesivir interferes with the viral RNA polymerase and why it does not block SARS-CoV-2 completely.

© Gerd Altmann/pixabay.com

European life sciences investors LSP has closed a new fund to fight dementia at €50m.

Pixabay

French Valneva SE announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.

© Pixabay.com

Immuno-oncology specialist Immunocore plc announced the completion of a $75m Series C private financing round.

Tumisu/ Pixabay.com

Following a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.

©  Pete Linforth/Pixabay.com

Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.

© NIAID

University of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results.